Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phenotyping Seroconversion Following Vaccination Against COVID-19 in Patients on Haemodialysis Study

NCT04815850 is registered in ClinicalTrials.gov with University of Leicester as lead sponsor.

NCT NCT04815850
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04815850 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phenotyping Seroconversion Following Vaccination Against COVID-19 in Patients on Haemodialysis Study
Lead sponsor
University of Leicester
Phase
Observational
Overall status
Completed
Start date
March 1, 2021
Completion date
December 5, 2022
Enrollment
115 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

end stage kidney disease